Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report

Figure 3

CT image for UPN 20 exhibited a partial response. A CT image showing the specific characteristics of the response of lung lesion following four cycles of decitabine treatment, assessing by the Response Evaluation Criteria in Solid Tumors (RECIST). The red arrows indicate the areas of measurable disease.